Range Low Price High Price Comment
30 days $114.96 $129.39 Friday, 23rd Feb 2024 DXCM stock ended at $116.26. This is 1.06% less than the trading day before Thursday, 22nd Feb 2024. During the day the stock fluctuated 2.14% from a day low at $116.01 to a day high of $118.49.
90 days $111.29 $132.03
52 weeks $74.75 $139.53

Historical DexCom prices

Date Open High Low Close Volume
2024-02-23 $117.13 $118.49 $116.01 $116.26 6 208 202
2024-02-22 $117.55 $118.00 $115.36 $117.50 3 034 958
2024-02-21 $117.00 $117.94 $115.34 $116.39 2 883 567
2024-02-20 $116.73 $119.10 $116.73 $117.87 3 092 595
2024-02-16 $116.83 $118.81 $116.36 $117.05 3 924 877
2024-02-15 $117.08 $118.51 $116.05 $117.69 3 079 415
2024-02-14 $117.03 $117.70 $114.96 $116.75 3 157 048
2024-02-13 $116.52 $120.24 $116.27 $117.03 3 286 161
2024-02-12 $119.53 $120.47 $117.15 $118.42 4 701 300
2024-02-09 $123.00 $124.99 $120.29 $120.47 5 602 563
2024-02-08 $127.20 $127.37 $125.21 $127.05 4 099 214
2024-02-07 $124.92 $127.09 $124.28 $126.61 2 237 764
2024-02-06 $121.81 $124.98 $120.47 $124.92 1 985 149
2024-02-05 $120.71 $121.80 $119.60 $121.23 2 713 015
2024-02-02 $122.21 $122.45 $119.63 $120.96 2 483 794
2024-02-01 $122.15 $123.84 $119.93 $122.60 2 067 815
2024-01-31 $121.23 $123.05 $120.12 $121.35 2 278 883
2024-01-30 $123.14 $123.24 $120.61 $120.79 2 578 357
2024-01-29 $121.88 $124.26 $119.55 $124.25 2 179 167
2024-01-26 $126.07 $126.39 $119.71 $121.96 3 729 665
2024-01-25 $129.14 $129.39 $125.24 $126.51 1 641 655
2024-01-24 $128.10 $128.56 $125.74 $127.42 1 644 242
2024-01-23 $129.15 $129.32 $125.39 $127.12 1 753 620
2024-01-22 $129.20 $130.31 $128.65 $129.29 3 133 329
2024-01-19 $127.12 $127.99 $125.06 $127.29 2 697 570
Click to get the best stock tips daily for free!

About DexCom

DexCom DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to i... DXCM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT